Macleod, D., Shanaube, K., Skalland, T., Limbada, M., Mandla, N., Bwalya, J., Schaap, A., Yang, B., Donnell, D., Piwowar-Manning, E., Eshleman, S. H., Hoddinott, G., Bond, V., Moore, A., Griffith, S., Bock, P., Ayles, H., Fidler, S., Hayes, R., Floyd, S., & , (2022). viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis. Lancet, 9(11), e751–e759. http://access.bl.uk/ark:/81055/vdc_100169185521.0x000001